COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1621: Articles 16201-16210  | Next

Estimating SARS-CoV-2 variant strain infectiousness in Japan as of March 28, 2021
Kurita, J., Sugawara, T., Ohkusa, Y. O.
10.1101/2021.04.11.21255283 — Posted: 2021-04-17
Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution
Van Egeren, D., Novokhodko, A., Stoddard, M., Tran, U., Joseph-McCarthy, D., Chakravarty, A.
10.1101/2021.04.10.21255251 — Posted: 2021-04-17
An explicit formula for minimizing the infected peak in an SIR epidemic model when using a fixed number of complete lockdowns
Sontag, E.
10.1101/2021.04.11.21255289 — Posted: 2021-04-17
A Single Drop of Fingerstick Blood for Quantitative Antibody Response Evaluation After SARS-CoV-2 Vaccination
Du, J., Zhang, D., May, H., Loginova, Y., Chu, E., Madej, R., Lu, C. M., Pathakamuri, J. A., Kuebler, D., Neves, J. V., Zhang, A., Sha, M. Y.
10.1101/2021.04.11.21255278 — Posted: 2021-04-17
Standardized and optimized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA
Natarajan, A., Han, A., Zlitni, S., Brooks, E. F., Vance, S. E., Wolfe, M., Singh, U., Jagannathan, P., Pinsky, B. A., Boehm, A., Bhatt, A. S.
10.1101/2021.04.10.21255250 — Posted: 2021-04-17
High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.525 lineage in Oyo State, Nigeria
Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., Lorenzo-Redondo, R.
10.1101/2021.04.09.21255206 — Posted: 2021-04-17
The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks
Billam, H., Francis, R. V., Clarke, M., Yates, C., Tsoleridis, T., Berry, L., Mahida, N., Irving, W. L., Moore, C., Holmes, N., Ball, J., McClure, C. P., Loose, M., The COG-UK consortium
10.1101/2021.04.15.21253894 — Posted: 2021-04-17
Can Social Media Data Be Utilized to Enhance Early Warning: Retrospective Analysis of the U.S. Covid-19 Pandemic
Li, L., Gao, L., Zhou, J., Ma, Z., Choy, D., Hall, M.
10.1101/2021.04.11.21255285 — Posted: 2021-04-17
The Community Opinions on Vaccine Issues and Decisions (COVID) Survey: Using a rapid Knowledge, Attitude and Practice (KAP) survey in supporting a community engagement approach to address COVID-19 vaccine uptake initiatives.
Rahman, N.
10.1101/2021.04.11.21255260 — Posted: 2021-04-17
Declines in life expectancy following the COVID-19 pandemic in provinces of Spain
Trias-Llimos, S., Blanes, A., Franco, M., Bilal, U., Riffe, T.
10.1101/2021.04.15.21255545 — Posted: 2021-04-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).